Segment disclosures

Company overview

SIGMA ALDRICH CORP

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

9 dimension combinations 153 retained observations 23 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Applied Business Unit

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:AppliedBusinessUnitMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30177000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2015-01-01 – 2015-09-30530000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2015-04-01 – 2015-06-30178000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2015-01-01 – 2015-06-30353000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2015-01-01 – 2015-03-31175000000 USD2015-05-07 · 13:48:19.000ZOpen filing evidence
2014-01-01 – 2014-12-31680000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2014-07-01 – 2014-09-30170000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2014-01-01 – 2014-09-30513000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2014-04-01 – 2014-06-30172000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2014-01-01 – 2014-06-30343000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2014-01-01 – 2014-03-31171000000 USD2015-05-07 · 13:48:19.000ZOpen filing evidence
2013-01-01 – 2013-12-31629000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2013-07-01 – 2013-09-30154000000 USD2014-10-23 · 13:50:20.000ZOpen filing evidence
2013-01-01 – 2013-09-30473000000 USD2014-10-23 · 13:50:20.000ZOpen filing evidence
2013-04-01 – 2013-06-30160000000 USD2014-07-24 · 16:50:27.000ZOpen filing evidence
2013-01-01 – 2013-06-30319000000 USD2014-07-24 · 16:50:27.000ZOpen filing evidence
2013-01-01 – 2013-03-31159000000 USD2014-04-24 · 18:16:11.000ZOpen filing evidence
2012-01-01 – 2012-12-31598000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2012-07-01 – 2012-09-30148000000 USD2013-10-22 · 16:28:05.000ZOpen filing evidence
2012-01-01 – 2012-09-30452000000 USD2013-10-22 · 16:28:05.000ZOpen filing evidence
2012-04-01 – 2012-06-30151000000 USD2013-07-23 · 16:13:13.000ZOpen filing evidence
2012-01-01 – 2012-06-30304000000 USD2013-07-23 · 16:13:13.000ZOpen filing evidence
2012-01-01 – 2012-03-31153000000 USD2013-04-25 · 16:21:51.000ZOpen filing evidence
2011-01-01 – 2011-12-31581000000 USD2014-02-06 · 17:34:54.000ZOpen filing evidence

Fine Chemicals Business Unit

Statement Business Segments

Multiple units reported for the same period; values are kept separate.

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:FineChemicalsBusinessUnitMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-31855000000 USD2013-02-07 · 17:20:18.000ZOpen filing evidence
2012-07-01 – 2012-09-30211000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2012-01-01 – 2012-09-30631000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2012-04-01 – 2012-06-30223000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2012-01-01 – 2012-06-30420000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2012-01-01 – 2012-03-31197000000 Unit1220120424Open filing evidence
2011-01-01 – 2011-12-31728000000 Unit1220120213Open filing evidence
2011-01-01 – 2011-12-31728000000 USD2013-02-07 · 17:20:18.000ZOpen filing evidence
2011-07-01 – 2011-09-30180000000 Unit1320111025Open filing evidence
2011-07-01 – 2011-09-30180000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2011-01-01 – 2011-09-30543000000 Unit1320111025Open filing evidence
2011-01-01 – 2011-09-30543000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2011-04-01 – 2011-06-30183000000 Unit1320110726Open filing evidence
2011-04-01 – 2011-06-30183000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2011-01-01 – 2011-06-30363000000 Unit1320110726Open filing evidence
2011-01-01 – 2011-06-30363000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2011-01-01 – 2011-03-31180000000 Unit1220120424Open filing evidence
2010-01-01 – 2010-12-31647000000 Unit1220120213Open filing evidence
2010-01-01 – 2010-12-31647000000 USD2013-02-07 · 17:20:18.000ZOpen filing evidence
2010-07-01 – 2010-09-30167000000 Unit1320111025Open filing evidence
2010-01-01 – 2010-09-30476000000 Unit1320111025Open filing evidence
2010-04-01 – 2010-06-30157000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-06-30309000000 Unit1320110726Open filing evidence
2009-01-01 – 2009-12-31593000000 Unit1220120213Open filing evidence

Research Biotech Business Unit

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:ResearchBiotechBusinessUnitMember
PeriodValueUnitFiledEvidence
2011-01-01 – 2011-12-31375000000 Unit1220120213Open filing evidence
2011-07-01 – 2011-09-3094000000 Unit1320111025Open filing evidence
2011-01-01 – 2011-09-30284000000 Unit1320111025Open filing evidence
2011-04-01 – 2011-06-3094000000 Unit1320110726Open filing evidence
2011-01-01 – 2011-06-30190000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-12-31345000000 Unit1220120213Open filing evidence
2010-07-01 – 2010-09-3084000000 Unit1320111025Open filing evidence
2010-01-01 – 2010-09-30258000000 Unit1320111025Open filing evidence
2010-04-01 – 2010-06-3083000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-06-30174000000 Unit1320110726Open filing evidence
2009-01-01 – 2009-12-31334000000 Unit1220120213Open filing evidence

Research Business Unit

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:ResearchBusinessUnitMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30346000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2015-01-01 – 2015-09-301021000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2015-04-01 – 2015-06-30340000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2015-01-01 – 2015-06-30675000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2015-01-01 – 2015-03-31335000000 USD2015-05-07 · 13:48:19.000ZOpen filing evidence
2014-01-01 – 2014-12-311404000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2014-07-01 – 2014-09-30347000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2014-01-01 – 2014-09-301063000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2014-04-01 – 2014-06-30357000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2014-01-01 – 2014-06-30716000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2014-01-01 – 2014-03-31359000000 USD2015-05-07 · 13:48:19.000ZOpen filing evidence
2013-01-01 – 2013-12-311402000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2013-07-01 – 2013-09-30341000000 USD2014-10-23 · 13:50:20.000ZOpen filing evidence
2013-01-01 – 2013-09-301055000000 USD2014-10-23 · 13:50:20.000ZOpen filing evidence
2013-04-01 – 2013-06-30353000000 USD2014-07-24 · 16:50:27.000ZOpen filing evidence
2013-01-01 – 2013-06-30714000000 USD2014-07-24 · 16:50:27.000ZOpen filing evidence
2013-01-01 – 2013-03-31361000000 USD2014-04-24 · 18:16:11.000ZOpen filing evidence
2012-01-01 – 2012-12-311398000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2012-07-01 – 2012-09-30335000000 USD2013-10-22 · 16:28:05.000ZOpen filing evidence
2012-01-01 – 2012-09-301055000000 USD2013-10-22 · 16:28:05.000ZOpen filing evidence
2012-04-01 – 2012-06-30348000000 USD2013-07-23 · 16:13:13.000ZOpen filing evidence
2012-01-01 – 2012-06-30720000000 USD2013-07-23 · 16:13:13.000ZOpen filing evidence
2012-01-01 – 2012-03-31372000000 USD2013-04-25 · 16:21:51.000ZOpen filing evidence
2011-01-01 – 2011-12-311427000000 USD2014-02-06 · 17:34:54.000ZOpen filing evidence

Research Chemicals Business Units

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:ResearchChemicalsBusinessUnitsMember
PeriodValueUnitFiledEvidence
2011-01-01 – 2011-12-311777000000 Unit1220120213Open filing evidence
2011-07-01 – 2011-09-30446000000 Unit1320111025Open filing evidence
2011-01-01 – 2011-09-301352000000 Unit1320111025Open filing evidence
2011-04-01 – 2011-06-30454000000 Unit1320110726Open filing evidence
2011-01-01 – 2011-06-30906000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-12-311624000000 Unit1220120213Open filing evidence
2010-07-01 – 2010-09-30396000000 Unit1320111025Open filing evidence
2010-01-01 – 2010-09-301213000000 Unit1320111025Open filing evidence
2010-04-01 – 2010-06-30397000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-06-30817000000 Unit1320110726Open filing evidence
2009-01-01 – 2009-12-311555000000 Unit1220120213Open filing evidence

Research Chemicals

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:ResearchChemicalsMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-311768000000 USD2013-02-07 · 17:20:18.000ZOpen filing evidence
2012-07-01 – 2012-09-30428000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2012-01-01 – 2012-09-301337000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2012-04-01 – 2012-06-30441000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2012-01-01 – 2012-06-30909000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2012-01-01 – 2012-03-31468000000 Unit1220120424Open filing evidence
2011-01-01 – 2011-12-311777000000 USD2013-02-07 · 17:20:18.000ZOpen filing evidence
2011-07-01 – 2011-09-30446000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2011-01-01 – 2011-09-301352000000 USD2012-10-23 · 16:15:40.000ZOpen filing evidence
2011-04-01 – 2011-06-30454000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2011-01-01 – 2011-06-30906000000 USD2012-07-24 · 16:14:14.000ZOpen filing evidence
2011-01-01 – 2011-03-31452000000 Unit1220120424Open filing evidence
2010-01-01 – 2010-12-311624000000 USD2013-02-07 · 17:20:18.000ZOpen filing evidence

Research Essentials Business Unit

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:ResearchEssentialsBusinessUnitMember
PeriodValueUnitFiledEvidence
2011-01-01 – 2011-12-31478000000 Unit1220120213Open filing evidence
2011-07-01 – 2011-09-30121000000 Unit1320111025Open filing evidence
2011-01-01 – 2011-09-30365000000 Unit1320111025Open filing evidence
2011-04-01 – 2011-06-30124000000 Unit1320110726Open filing evidence
2011-01-01 – 2011-06-30244000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-12-31434000000 Unit1220120213Open filing evidence
2010-07-01 – 2010-09-30105000000 Unit1320111025Open filing evidence
2010-01-01 – 2010-09-30324000000 Unit1320111025Open filing evidence
2010-04-01 – 2010-06-30107000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-06-30219000000 Unit1320110726Open filing evidence
2009-01-01 – 2009-12-31425000000 Unit1220120213Open filing evidence

Research Specialties Business Unit

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:ResearchSpecialtiesBusinessUnitMember
PeriodValueUnitFiledEvidence
2011-01-01 – 2011-12-31924000000 Unit1220120213Open filing evidence
2011-07-01 – 2011-09-30231000000 Unit1320111025Open filing evidence
2011-01-01 – 2011-09-30703000000 Unit1320111025Open filing evidence
2011-04-01 – 2011-06-30236000000 Unit1320110726Open filing evidence
2011-01-01 – 2011-06-30472000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-12-31845000000 Unit1220120213Open filing evidence
2010-07-01 – 2010-09-30207000000 Unit1320111025Open filing evidence
2010-01-01 – 2010-09-30631000000 Unit1320111025Open filing evidence
2010-04-01 – 2010-06-30207000000 Unit1320110726Open filing evidence
2010-01-01 – 2010-06-30424000000 Unit1320110726Open filing evidence
2009-01-01 – 2009-12-31796000000 Unit1220120213Open filing evidence

Safc Commercial Business Unit

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sial:SafcCommercialBusinessUnitMember
PeriodValueUnitFiledEvidence
2015-07-01 – 2015-09-30180000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2015-01-01 – 2015-09-30525000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2015-04-01 – 2015-06-30179000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2015-01-01 – 2015-06-30345000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2015-01-01 – 2015-03-31166000000 USD2015-05-07 · 13:48:19.000ZOpen filing evidence
2014-01-01 – 2014-12-31701000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2014-07-01 – 2014-09-30173000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2014-01-01 – 2014-09-30504000000 USD2015-11-03 · 14:53:26.000ZOpen filing evidence
2014-04-01 – 2014-06-30172000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2014-01-01 – 2014-06-30331000000 USD2015-07-30 · 14:38:31.000ZOpen filing evidence
2014-01-01 – 2014-03-31159000000 USD2015-05-07 · 13:48:19.000ZOpen filing evidence
2013-01-01 – 2013-12-31673000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2013-07-01 – 2013-09-30169000000 USD2014-10-23 · 13:50:20.000ZOpen filing evidence
2013-01-01 – 2013-09-30492000000 USD2014-10-23 · 13:50:20.000ZOpen filing evidence
2013-04-01 – 2013-06-30168000000 USD2014-07-24 · 16:50:27.000ZOpen filing evidence
2013-01-01 – 2013-06-30323000000 USD2014-07-24 · 16:50:27.000ZOpen filing evidence
2013-01-01 – 2013-03-31155000000 USD2014-04-24 · 18:16:11.000ZOpen filing evidence
2012-01-01 – 2012-12-31627000000 USD2015-02-12 · 20:58:50.000ZOpen filing evidence
2012-07-01 – 2012-09-30156000000 USD2013-10-22 · 16:28:05.000ZOpen filing evidence
2012-01-01 – 2012-09-30461000000 USD2013-10-22 · 16:28:05.000ZOpen filing evidence
2012-04-01 – 2012-06-30165000000 USD2013-07-23 · 16:13:13.000ZOpen filing evidence
2012-01-01 – 2012-06-30305000000 USD2013-07-23 · 16:13:13.000ZOpen filing evidence
2012-01-01 – 2012-03-31140000000 USD2013-04-25 · 16:21:51.000ZOpen filing evidence
2011-01-01 – 2011-12-31497000000 USD2014-02-06 · 17:34:54.000ZOpen filing evidence